Human medicines European public assessment report (EPAR): NovoSeven, eptacog alfa (activated), Hemophilia B,Thrombasthenia,Factor VII Deficiency,Hemophilia A, Date of authorisation: 23/02/1996, Revision: 32, Status: Authorised

2019 ◽  
Author(s):  
Keyword(s):  
Hemophilia A ◽  
Hemophilia B ◽  
Factor Vii ◽  
Assessment Report ◽  
Factor Vii Deficiency ◽  
European Public ◽  
European Public Assessment Report
Sign in / Sign up

Export Citation Format

Share Document